ARROWHEAD PHARMACEUTICALS, INC. Deferred Tax Assets, Capital Loss Carryforwards
ARROWHEAD PHARMACEUTICALS, INC. (ARWR) had Deferred Tax Assets, Capital Loss Carryforwards of $1.68 million as of 2022-09-30, per its 10-K filed 2022-11-28.
Discontinued › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsCapitalLossCarryforwards · last filed 2022-11-28
- 2022-09-30: Deferred Tax Assets, Capital Loss Carryforwards $1.68M.
- 2021-09-30: Deferred Tax Assets, Capital Loss Carryforwards $0.00.
- 2020-09-30: Deferred Tax Assets, Capital Loss Carryforwards $710.00K; Deferred Tax Assets, Capital Loss Carryforwards as first filed $709.78K.
- 2019-09-30: Deferred Tax Assets, Capital Loss Carryforwards $709.78K.
| Period end | Deferred Tax Assets, Capital Loss Carryforwards | Deferred Tax Assets, Capital Loss Carryforwards as first filed |
|---|---|---|
| 2022-09-30 | $1.68M 10-K · filed 2022-11-28 | |
| 2021-09-30 | $0.00 10-K · filed 2022-11-28 | |
| 2020-09-30 | $710.00K 10-K · filed 2021-11-22 | $709.78K 10-K · filed 2020-11-23 |
| 2019-09-30 | $709.78K 10-K · filed 2020-11-23 | |
| 2018-09-30 | $709.78K 10-K · filed 2019-11-25 | |
| 2017-09-30 | $1.02M 10-K · filed 2018-12-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 |